These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 32849597

  • 41. Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease.
    Kotomina T, Isakova-Sivak I, Matyushenko V, Kim KH, Lee Y, Jung YJ, Kang SM, Rudenko L.
    Antiviral Res; 2019 Aug; 168():9-17. PubMed ID: 31075351
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
    Kishko M, Catalan J, Swanson K, DiNapoli J, Wei CJ, Delagrave S, Chivukula S, Zhang L.
    Virology; 2020 Nov; 550():21-26. PubMed ID: 32866728
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. The role of IFN in respiratory syncytial virus pathogenesis.
    Durbin JE, Johnson TR, Durbin RK, Mertz SE, Morotti RA, Peebles RS, Graham BS.
    J Immunol; 2002 Mar 15; 168(6):2944-52. PubMed ID: 11884466
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R, Shao M, Mackman RL, Perron M, Cihlar T, Lewis SA, Eisenberg EJ, Carey A, Strickley RG, Chien JW, Anderson ML, McEligot HA, Behrens NE, Gershwin LJ.
    Antimicrob Agents Chemother; 2015 Aug 15; 59(8):4889-900. PubMed ID: 26055364
    [Abstract] [Full Text] [Related]

  • 50. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P, Wang Y, Liu H, Yang Y, Wu X, Wei H, Chen T.
    Front Cell Infect Microbiol; 2019 Aug 15; 9():275. PubMed ID: 31417879
    [Abstract] [Full Text] [Related]

  • 51. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L, Schmidt MR, Morrison TG.
    J Virol; 2019 May 01; 93(9):. PubMed ID: 30760576
    [Abstract] [Full Text] [Related]

  • 52. Humoral and cellular immunity to RSV in infants, children and adults.
    Green CA, Sande CJ, de Lara C, Thompson AJ, Silva-Reyes L, Napolitano F, Pierantoni A, Capone S, Vitelli A, Klenerman P, Pollard AJ.
    Vaccine; 2018 Oct 01; 36(41):6183-6190. PubMed ID: 30177258
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice.
    Tripp RA, Moore D, Winter J, Anderson LJ.
    J Virol; 2000 Feb 01; 74(4):1614-22. PubMed ID: 10644330
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Inhibition of FcγR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcγRIIb in human macrophages.
    Nagelkerke SQ, Dekkers G, Kustiawan I, van de Bovenkamp FS, Geissler J, Plomp R, Wuhrer M, Vidarsson G, Rispens T, van den Berg TK, Kuijpers TW.
    Blood; 2014 Dec 11; 124(25):3709-18. PubMed ID: 25352126
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.